Pharmacoeconomical aspects of treatment of sharp intestinal infections at children

  • J. Maynich -
  • О. Sichkoriz -
  • О. Zaliska -
Keywords: the pharmacoeconomical analysis, children, sharp intestinal infections

Abstract

The analysis of statistics of desease, has shown, that among 75 % hospitalized in children’s branch children with gastroenterocolitis established etiology (represent 49 %), gastroenterocolitis unstated eti­ology (14 %), and salmonele (12 %) sharp intestinal infections -SII. The carried out analysis of practical circuits of pharmacotherapy SII at children has shown, that the nomenclature of medical products totals about 130 names. The resulted ranged number of medical products depending on pharmacotherapeutic groups. The analysis of the data of Evidence-based medicine and database Cochrane about effectiveness of medical products is carried out at SII at children. Cost indexes of pharmacotherapy and diagnostic SII at children by antibacterial means and probiotics for hospitalization are designed.

References

Boyko AI Marketing and pharmacoeconomic research of drugs for the treatment of diabetes: Abstract. dis .... cand. pharmacy. Science. - Lviv, 2005. - 20 p.

Viktorov OP, Bikanova II // Pharmac. magazine. - 2007. - № 4. - S. 27—31.

Gromovik BP // Pharmacist. - 2000. - № 17. - S. 19—22.

Zaliska OM // Pharmac. magazine. - 2001. - № 3. - S. 3—10.

Zaliska OM Theoretical foundations and practical use of pharmacoeconomics in Ukraine: Abstract. dis .... Dr. Pharmac. - Lviv, 2004. - 33 p.

Zimenkovsky A., Syatinya V. // Medicines of Ukraine. - 2003. - № 7—8. - S. 57—59.

Zupanets IA, Nemchenko AS // Pharmacist. - 2001. - № 23. - P. 13—19.

Order of the Ministry of Health of Ukraine dated 09.07.2004 № 354. "On approval of protocols for diagnosis and treatment of infectious diseases in children" // Ukr. honey. magazine. - 2005. - № 2. - S. 120—144.

Nemchenko AS, Galiy LV // Medicines of Ukraine. - 2001. - № 5 (46). - S. 21—26.

Nemchenko A., Podkolozina M. // Ibid. - 2001. - № 1. - S. 9—12.

Nyankoeysky S., Gerasimov S., Troshkov O., Zarychansky J. // Ibid. - 2005. - № 3. - S. 46—50.

Agostoni C., Axelson I., Braegger C. et al. //.. Pediatr. Gastroenterol. Nutr. - 2004. - Vol. 38. ó P. 365ó374.

Allen SJ., Okoko B., Martinez E. et al. Probiotics for treating infectious diarrhea (Cochrane Review). - The Cochrane Database of Systematic Reviews. - Issue 4 - 2003

Drummond M., Pang F. Transferability of economic evaluation results. // Drummond MF, McGuire AL, eds., Economic Evaluation of Health Care: Merging Theory with Practice. - Oxford: Oxford University Press, 2001. - 305 p.

Gold MR., Siegel JE., Russell LB. et al. Cost-Effectiveness in Health and Medicine. - New York: Oxford University Press, 1996. - 284 p.

Sirinavin S, Garner P. // The Cochrane Database of Systematic Reviews. - 1999. - Issue 1.

Szajewska H., Mrukowicz J. Z. // J. Pediatr. Gastroenterol. Nutr. - 2001. - Vol. 33. ó P. 17ó25.

Van Niel C., Feudtner C., Garrison M.M. et al. // Pediatrics. - 2002. - Vol. 109. ó P. 678ó684.

WHO’s Medicines Strategy 2004-2007. www./who./int/

Published
2008-08-26
How to Cite
Maynich, J., SichkorizО., & ZaliskaО. (2008). Pharmacoeconomical aspects of treatment of sharp intestinal infections at children. Farmatsevtychnyi Zhurnal, (4), 15-21. Retrieved from https://pharmj.org.ua/index.php/journal/article/view/1112
Section
Management, marketing and logistics